HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William T Regenold Selected Research

ethyl 1- benzyl- 3- hydroxy- 2(5H)- oxopyrrole- 4- carboxylate

9/2002Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William T Regenold Research Topics

Disease

4Schizophrenia (Dementia Praecox)
01/2019 - 11/2008
4Bipolar Disorder (Manic Depressive Psychosis)
01/2019 - 11/2008
4Mitochondrial Diseases (Mitochondrial Disease)
01/2017 - 12/2008
2Alzheimer Disease (Alzheimer's Disease)
01/2018 - 09/2017
2Mental Disorders (Mental Disorder)
01/2017 - 06/2002
2Neurologic Manifestations (Neurological Manifestations)
05/2014 - 11/2008
2Mood Disorders (Mood Disorder)
02/2012 - 04/2005
2Psychotic Disorders (Schizoaffective Disorder)
04/2005 - 06/2002
1Fatigue
01/2019
1Stroke (Strokes)
01/2019
1Brain Diseases (Brain Disorder)
01/2018
1Cognitive Dysfunction
09/2017
1Dementia (Dementias)
09/2017
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
09/2017
1Major Depressive Disorder (Major Depressive Disorders)
09/2015
1Hyperammonemia
01/2015
1Neurosyphilis (General Paresis of the Insane)
05/2014
1Hypersensitivity (Allergy)
02/2012
1Seasonal Affective Disorder
02/2012
1Tardive Dyskinesia
02/2009
1Disease Progression
12/2008
1Multiple Sclerosis
12/2008
1Mania (Manias)
04/2006
1Diabetes Mellitus
04/2005
1Treatment-Resistant Depressive Disorder
09/2004
1Epilepsy (Aura)
09/2004
1Neoplasms (Cancer)
09/2002
1Carcinoma (Carcinomatosis)
09/2002
1Type 2 Diabetes Mellitus (MODY)
06/2002
1Hyperglycemia
06/2002
1Weight Gain
06/2002

Drug/Important Bio-Agent (IBA)

6Glucose (Dextrose)FDA LinkGeneric
03/2009 - 06/2002
3Valproic Acid (Depakote)FDA LinkGeneric
01/2018 - 04/2006
2Sorbitol (Yal)FDA Link
04/2005 - 09/2002
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
01/2019
1Indicators and Reagents (Reagents)IBA
01/2019
1C-Reactive ProteinIBA
01/2019
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2018
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2017
1CreatinineIBA
09/2017
1Anti-Bacterial Agents (Antibiotics)IBA
01/2017
1Biomarkers (Surrogate Marker)IBA
04/2015
1Proteins (Proteins, Gene)FDA Link
01/2015
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2015
1Penicillins (Penicillin)FDA Link
05/2014
1ragweed pollenIBA
02/2012
1Immunoglobulin E (IgE)IBA
02/2012
1AllergensIBA
02/2012
1Lactic Acid (Lactate)FDA LinkGeneric
03/2009
1Donepezil (Aricept)FDA LinkGeneric
02/2009
1myo-inositol-1 (or 4)-monophosphatase (inositol monophosphatase)IBA
04/2006
1Inositol (Myoinositol)IBA
04/2006
1LithiumIBA
04/2006
1Therapeutic UsesIBA
04/2006
1polyolIBA
04/2005
1gamma-Aminobutyric Acid (GABA)IBA
09/2004
1Antidepressive Agents (Antidepressants)IBA
09/2004
1Neurotransmitter Agents (Neurotransmitter)IBA
09/2004
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2002
1Cisplatin (Platino)FDA LinkGeneric
09/2002
1Antineoplastic Agents (Antineoplastics)IBA
09/2002
1Aldehyde Reductase (Aldose Reductase)IBA
09/2002
1ethyl 1- benzyl- 3- hydroxy- 2(5H)- oxopyrrole- 4- carboxylateIBA
09/2002
1Psychotropic Drugs (Psychoactive Drugs)IBA
06/2002
1Olanzapine (Zyprexa)FDA Link
06/2002
1Clozapine (Clozaril)FDA LinkGeneric
06/2002
1PhenothiazinesIBA
06/2002

Therapy/Procedure

3Therapeutics
09/2015 - 12/2008
1Electric Stimulation Therapy (Electrotherapy)
09/2015
1Vagus Nerve Stimulation
09/2004